 |
Ocular
Microbiology and Immunology Group (OMIG)
Back
to OMIG Main Page
2007
Abstracts and Meeting Agenda
Agenda
Ocular Microbiology and Immunology Group
41st Annual Meeting
Wyndham New Orleans at Canal Place
New Orleans, Louisiana
November 9, 2007
MODERATORS: Michael Zegans, M.D., Ph.D.
James Chodosh, M.D.
| 6:45 am |
Registration |
| 7:30 am |
Memorial to Gil Smolin by John Whitcher |
| 7:38 am |
The SICCA Study: Preliminary Results from Ocular Examinations in 736 Patients
John Whitcher (Proctor/UCSF), Ana Heidenreich (UBA,GH), Zhang Shunhua (PUMCH), Sven Johansen (CUH,G), Kazuko Kitagawa (KMU), Erich Strauss (UCSF), Steve Pflugfelder, and Austin Mircheff (Consultants) |
| 7:46 am |
The Rise and Fall of Antibiotic Resistance in Pneumococcus After Mass Azithromycin Distributions for Trachoma.
Sara Haug1,2, Vicky Cevallos1, Jenafir House1, Wondu Alemayu4, Takele Lakew4, Tina Rutar13, Jack Whitcher1,3, Bruce Gaynor1,3, Tom Lietman1,3 and the TEF trachoma team in Ethiopia (1F.I. Proctor Foundation, UCSF, 2UCSF School of Medicine, 3Department of Ophthalmology, UCSF, 4Orbis-Ethiopia) |
| 7:54 am |
Use of Cumulative MIC Distributions to Document Shifting (Declining) Vancomycin Susceptibility Trends Among Ocular Gram Positive Pathogen Populations.
Darlene Miller DHSC, MPH, Eduardo C. Alfonso, MD, Edith Perez BS, Martha Diaz BS Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami School of Medicine, Miami, FL. |
| 8:02 am |
Change in the Incidence of Non-Tuberculous Mycobacteria Related Keratitis in the Fourth Generation Fluoroquinolone Era.
Jayrag Patel, Mahendra K. Shah, David C. Ritterband, Carolyn Shih, John A. Seedor, Richard S. Koplin. Departments of Ophthalmology and Laboratory Medicine, The New York Eye and Ear Infirmary, New York, NY and New York Medical College, Valhalla, NY |
| 8:10 am |
Stromal Graft Rejection: A Silent Menace.
Jerome C. Ramos-Esteban, MD, William J. Dupps, MD, PhD, David M. Meisler, MD, Bennie H. Jeng, MD Cole Eye Institute, Cleveland, OH |
| 8:18 am |
Inhibition of Bacterial Peptidoglycan, Muramyl Dipeptide-Induced Apoptosis By Indomethacin In Vitro And In Vivo.
Marlyn P. Langford, Chanping Liang, Katia E. Taba, Thomas B. Redens and Donald E. Texada Department of Ophthalmology, Louisiana State University Health Sciences Center, Shreveport, LA |
| 8:26 am |
Ocular Rhinosporidiosis as a Cause of Chronic Follicular Conjunctivitis.Leejee H. Suh, Sander R. Dubovy, Joseph Barron, Jack Fell, Dolena R. Ledee, Livia Bajenaru, & Richard K. Forster. Bascom Palmer Eye Institute, Miami, FL |
| 8:34 am |
Evidence for Propionibacterium acnes as a Conjunctival Pathogen. D.W. Stroman, J.G. Bartell, B.A. Schlech. Alcon Research, Ltd., Fort Worth, TX |
| 8:42 am |
Rate of Suture-Related Corneal Infections After Cataract Surgery.
Bennie H. Jeng, Brian J. Lee, Scott D. Smith. Cole Eye Institute, Cleveland Clinic |
| 8:50 am |
A Fluoroquinolone (FQ)-Resistant Staphylococcus aureus Rabbit Endophthalmitis Model Demonstrates a Topical 4th Generation FQ Provides More Effective Prophylaxis Than a 3rd Generation FQ. E.G. Romanowski1, R. P. Kowalski1, F. S. Mah1, K. A. Yates1, H. Sasaki2, M. Fukuda2, Y. J. Gordon1. 1The Charles T. Campbell Ophthalmic Microbiology Laboratory, UPMC Eye Center, University of Pittsburgh, Pittsburgh, PA., 2Department of Ophthalmology, Division of Sensory Organ Medicine, Kanazawa Medical University, Kahoku, Ishikawa, Japan |
| 8:58 am |
Fluoroquinolone Prophylaxis for Experimental MRSA Keratitis in a LASIK Model.
C. McCormick1, C Balzli1, A Caballero1, A Tang1, B Huang2, and R O’Callaghan1 University of Mississippi Medical Center, Jackson, MS, USA Department of Microbiology1, Department of Ophthalmology2 |
| 9:06 am |
The Ocular Distribution and Kinetics of Moxifloxacin Following Prophylactic Dosing Regimens and an Intracameral Injection in Rabbits.G. R. Owen, L.F. Bernal-Perez, A.C. Brooks. Alcon Research, Ltd., Fort Worth, TX |
| 9:14 am |
Utilizing a Hydrophilic Intraocular Lens for Intraocular Drug Delivery.Lisa M. Nijm1*, Elmer Y. Tu1, Lawrence J. Ulanski, II1 Rick Fiscella, Jr.1, Randall Peterson2. 1Department of Ophthalmology, University of Illinois Eye and Ear Infirmary, Chicago, IL; 2Springfield Clinic Eye Institute, Springfield, IL. |
| 9:22 am |
Topical Gatifloxacin 0.3% Can Prevent Staphylococcus aureus-Induced Clinical Endophthalmitis in a Clear Cornea Incision Rabbit Model.
R.P. Kowalski, E.G. Romanowski, F.S. Mah, K.A. Yates, H. Weirback, L. Zhang, Y.J. Gordon. The Charles T. Campbell Laboratory, University of Pittsburgh, Pittsburgh, PA. |
| 9:30 am |
Acanthamoeba Keratitis: Risk Factors, Clinical Characteristics and Outcomes.
S.A. Iyer, S.S. Tuli, W. T. Driebe. University of Florida, Gainesville |
| 9:38 am |
The Continuing Rise of Acanthamoeba Keratitis.
Hall F. Chew, MD, Kristin M. Hammersmith, MD, Christopher J. Rapuano, MD, Brandon D. Ayres, MD, Peter R. Laibson, MD, Ralph C. Eagle Jr, MD, and Elisabeth J. Cohen, MD Cornea Service, Wills Eye Institute, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA. |
| 9:46 am |
Twenty Years of Acanthamoeba Keratitis in Brazil.
Freitas D, Carvalho FRS, Foronda AS, Aoki AM, Zorat-Yu MC, Belfort Jr R, Höfling-Lima AL. Ophthalmology Department, Federal University of São Paulo |
| 9:54 am |
Investigation of the Role of a Taurine-Containing Contact Lens Disinfection Solution in the Ongoing Acanthamoeba Keratitis Outbreak.Elmer Y Tu1, Megan E Shoff2, Charlotte E Joslin1, Laura Kubatko3, Paul A Fuerst2. 1University of Illinois at Chicago, Department of Ophthalmology, 2The Ohio State University, Department of Evolution, Ecology, and Organismal Biology, 3The Ohio State University, Division of Epidemiology and Biostatistics. |
| 10:02 am |
Risk Factors and Means of Detection of Acanthamoeba Keratitis at the New York Eye and ear Infirmary 2005-2007.
Lior Haim, Boris Ovodenko, Mahendra Shah, David Ritterband, John Seedor. Departments of Ophthalmology and Laboratory Medicine, The New York Eye and Ear Infirmary, New York, NY and New York Medical College, Valhalla, NY |
| 10:10 am |
Fusarium and Acanthamoeba Keratitis: Can A Single Center Detect Outbreaks?
Agnieszka Nagpal, MD1, Wiwan Sansanayudh, MD1, Vicky Cevallos, BS1, Travis C. Porco, PhD, MPH1,2, Todd P. Margolis, MD PhD1,3, Thomas M. Lietman, MD1,2,3, and Nisha R. Acharya MD, MS1,3
1The F.I. Proctor Foundation, University of California, San Frncisco; 2Department of Epidemiology and Biostatistics, University of California, San Francisco; 3Department of Ophthalmology, University of California, San Francisco. |
| 10:18 am |
Fungal Keratitis:Emerging Trends and Treatment Outcomes.
Sonal Tuli, Sandhya Iyer, William Driebe.University of Florida, Gainesville, FL |
| 10:26 am |
Genotypic Identification of Fusarium sp from Ocular Sources in South Florida.
R.A. Oechsler RA, Feilmeier M, Ledee D, Miller D, Fini ME, Fell J, Alfonso E. Bascom Palmer Eye Institute – Miller School of Medicine – University of Miami |
| 10:34 am |
In Vivo Morphology of Corneal Nerves and Corneal Sensation in Herpes Simplex Keratitis.
Pedram Hamrah, MD : Mohammad H. Dastjerdi, MD, Reza Dana, MD, MPH, MSc, Deborah Pavan-Langston, MD |
| 10:42 am |
Thygeson Lecture – Sally Atherton, PhD
“Herpes Simplex Virus Infections: From the Outside in?”
|
| 11:07 am |
Closing Comments and Awards
|
| 11:15 am |
Adjourn |
View
OMIG Meeting Commercial Relationship Policy
View OMIG 2007 Information Letter
OMIG
Contact information:
John Sutphin, MD (jsutphin@kumc.edu)
University ofr Kansas Medical Center
3901 Rainbow Blvd, MS 3009
Kansas City, Kansas 66106
Phone (913) 588-0888
View
Previous OMIG Meetings Abstracts
2006 Abstracts 2006 Meeting, Nov 10, 2006, Las Vegas, NV
2005
Abstracts 2005 Meeting, Oct 15, 2005, Chicago, IL
2004 Abstracts
2004 Meeting, Oct. 23, 2004, New Orleans,
LA
2003
Abstracts 2003 Meeting, Nov. 15, 2003, Anaheim, CA
2002
Abstracts 2002 Meeting, Oct.19, 2002, Orlando, FL
2001
Abstracts 2001 Meeting, Nov.10, 2001, New Orleans, LA
|
 |
Image of Ocular
Microbiology and Immunology Group (OMIG) logo.
|
